• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
The 2010-2015 Outlook for Drug Discovery Technologies in Latin America - Product Image

The 2010-2015 Outlook for Drug Discovery Technologies in Latin America

  • ID: 1067247
  • May 2009
  • Region: America, Latin America
  • 35 pages
  • ICON Group International

WHAT IS LATENT DEMAND AND THE P.I.E.?

The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable or not yet realized. Demand is the notion of an economic quantity that a target population or market requires under different assumptions of price, quality, and distribution, among other factors. Latent demand, therefore, is commonly defined by economists as the industry earnings of a market when that market becomes accessible and attractive to serve by competing firms. It is a measure, therefore, of potential industry earnings (P.I.E.) or total revenues (not profit) if a market is served in an efficient manner. It is typically expressed as the total revenues potentially extracted by firms. The “market” is defined at a given level in the value chain. There can be latent demand at the retail level, at the wholesale level, the manufacturing level, and the raw materials level (the P.I.E. of higher levels of the value chain being always smaller than the P.I.E. of levels at lower levels of the same value chain, assuming all levels maintain minimum profitability).

The latent demand for drug discovery technologies READ MORE >

1 INTRODUCTION 1
1.1 Overview 1
1.2 What is Latent Demand and the P.I.E.? 1
1.3 The Methodology 2
1.3.1 Step 1. Product Definition and Data Collection 4
1.3.2 Step 2. Filtering and Smoothing 5
1.3.3 Step 3. Filling in Missing Values 6
1.3.4 Step 4. Varying Parameter, Non-linear Estimation 6
1.3.5 Step 5. Fixed-Parameter Linear Estimation 7
1.3.6 Step 6. Aggregation and Benchmarking 7
1.3.7 Step 7. Latent Demand Density: Allocating Across Cities 7
2 LATIN AMERICA 9
2.1 Executive Summary 9
2.2 Argentina 10
2.3 Belize 11
2.4 Bolivia 12
2.5 Brazil 13
2.6 Chile 14
2.7 Colombia 15
2.8 Costa Rica 16
2.9 Ecuador 16
2.10 El Salvador 17
2.11 French Guiana 18
2.12 Guatemala 18
2.13 Guyana 19
2.14 Honduras 20
2.15 Mexico 21
2.16 Nicaragua 22
2.17 Panama 22
2.18 Paraguay 23
2.19 Peru 24
2.20 Suriname 25
2.21 The Falkland Islands 25
2.22 Uruguay 26
2.23 Venezuela 27
3 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 28
3.1 Disclaimers & Safe Harbor 28
3.2 Icon Group International, Inc. User Agreement Provisions 29

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos